Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of elafin in patients with acute postoperative complications following resection of esophageal cancer surgery (ECS).

Next Previous
Trial Profile

Effect of elafin in patients with acute postoperative complications following resection of esophageal cancer surgery (ECS).

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 21 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tiprelestat (Primary)
  • Indications Postoperative inflammation
  • Focus Registrational; Therapeutic Use
  • Acronyms POSTCOM
  • Sponsors tiakis Biotech

Most Recent Events

  • 01 Sep 2022 According to a Tiakis Biotech media release, Proteo Biotech has changed its name to Tiakis Biotech.
  • 18 Dec 2017 According to a Proteo Biotech media release, based on the European Medicines Agency advice letter, comapny is planning the trial
  • 27 Mar 2015 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top